103 Days
Source:
الصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
103 Daysالصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
103 DaysReady to play
Ready to play
A study has shown that a new treatment based on an mRNA vaccine, given alongside an immunotherapy drug, reduces the risk of skin cancer recurrence by 49% after surgical removal in advanced stages. Researchers conducted trials on 157 patients and confirmed the therapy's effectiveness and durability, with only mild side effects. The treatment is still in the final stages of clinical trials before widespread approval.
Notice: This Is an AI-Generated Summary
Comments (0)